Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Structural Change and Economic Dynamics|March 23, 2022
Predicting the spread of COVID-19 in Italy using machine learning: Do socio-economic factors matter?Francesco Bloise, Massimiliano Tancioni
Future Oncology (London, England)|December 25, 2019
Dedifferentiated liposarcoma: when eribulin can make the differenceAndrea Sbrana, Federico Paolieri, Francesco Bloise, et al.
Immunotherapy|March 28, 2025
Incidence and impact of immune combination therapies adverse events in advanced renal cell carcinoma patientsMartina Catalano, Giulia Venturi, Alessia Salfi, et al.
Journal of Personalized Medicine|July 27, 2022
Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. <i>J. Pers. Med.</i> 2022, <i>12</i>, 555Maria Antonietta Mazzei, Giulio Bagnacci, Armando Perrella, et al.
Biomedical Reports|March 20, 2020
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer serviceAndrea Sbrana, Federico Paolieri, Francesco Bloise, et al.
Journal of Geriatric Oncology|November 2, 2019
Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapyAndrea Sbrana, Rachele Antognoli, Giuseppe Pasqualetti, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2020
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abirateroneStefania Crucitta, Marzia Del Re, Federico Paolieri, et al.
Therapeutic Advances in Urology|January 20, 2026
Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy, safety, and risk stratificationMartina Catalano, Sara Bartoli, Alessia Salfi, et al.
British Journal of Cancer|March 7, 2018
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLCMarzia Del Re, Riccardo Marconcini, Giulia Pasquini, et al.
Journal of Translational Medicine|August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIsMarzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Pageof 2